Neurometrix Inc (NURO)

[mick]

#2/ NeuroMetrix Announces Quell Distribution in Canada
June 14, 2016 02:26 PM Eastern Daylight Time
WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell® Wearable Pain Relief Technology™ is available in Canada via Amazon Canada.

http://www.businesswire.com/news/home/20160614006290/en/
http://www.businesswire.com/
http://www.businesswire.com/portal/site/home/news/
http://www.businesswire.com/portal/site/home/news/industries/
http://www.businesswire.com/portal/site/home/news/subjects/
http://www.businesswire.com/portal/site/home/events/


NeuroMetrix Announces Quell Distribution in Canada
Tweet this
"Canadian consumers have been asking for easier access to Quell," said Frank McGillin, SVP and General Manager of NeuroMetrix. "This is an important step as we look to expand availability of our patented, 100% drug free technology for the relief of widespread chronic pain.” Canadian consumers can now purchase Quell locally on Amazon.ca.


About Quell

Quell is FDA cleared and designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell gives users the option to start, stop, and adjust therapy discreetly via their smartphone. It also enables advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. Quell is available at select healthcare professionals and retailers. To find a Quell retailer near you, visit the Store Locator at QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit

http://www.NeuroMetrix.com.

Contacts
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
[e-mail]